Table 2 Comparison between BRVO-affected eyes, contralateral eyes and control eyes.

From: The measurement and correlation analysis of scleral and choroid thickness in branch retinal vein occlusion

Category

BRVO-affected eyes

Contralateral eyes

Control eyes

t1

t2

t3

P1

P2

P3

SFCT (μm)

391.88 ± 38.70

246.18 ± 18.13

235.41 ± 10.50

19.88

24.27

− 3.15

 < 0.001*

 < 0.001*

0.002

Temporal ST (μm)

447.88 ± 50.55

388.62 ± 29.76

384.67 ± 60.55

5.89

4.80

− 0.35

 < 0.001*

 < 0.001*

0.73

Nasal ST (μm)

466.38 ± 47.24

357.82 ± 25.03

389.28 ± 51.00

11.84

6.67

3.27

 < 0.001*

 < 0.001*

0.002

Superior ST (μm)

478.44 ± 53.43

346.59 ± 28.70

389.69 ± 53.23

12.68

7.09

4.21

 < 0.001*

 < 0.001*

 < 0.001*

Inferior ST (μm)

455.32 ± 49.08

341.47 ± 27.00

385.18 ± 46.82

11.86

6.24

4.79

 < 0.001*

 < 0.001*

 < 0.001*

  1. BRVO branch retina vein occlusion, SFCT subfoveal choroid thickness, ST scleral thickness.
  2. t1 and P1: statistical values for comparisons between BRVO-affected and contralateral eyes; t2 and P2: statistical values for comparisons between BRVO-affected and control eyes;t3 and P3: Statistical values for comparisons between contralateral eyes and control eyes; P < 0.05 was statistically significant; * indicates P < 0.001.
Back to article page